Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn

Drug Screening

BioPhotonics
Apr 2010
Request Info
 
A label-free drug discovery technology called Soprano has been introduced by PharmaDiagnostics NV. The screening tool, which does not require special equipment, uses a technique called localized surface plasmon resonance to analyze small molecules and proteins of interest using gold nanoparticles. It uses a standard plate reader and a 96- or 384-well format to analyze enzymatic reactions, ADME/PK, or ligand receptor and protein binding.


REQUEST INFO ABOUT THIS PRODUCT

* Message:
(requirements, questions for supplier)
Your contact information
* First Name:
* Last Name:
* Email Address:
* Company:
Address:
Address 2:
City:
State/Province:
Postal Code:
* Country:
Phone #:
Fax #:

Register or login to auto-populate this form:
Login Register
* Required
384-well96-wellADMEbiophotonicsBreakthroughProductsdrug discoveryenzymatic reactionsgold nanoparticlelabel-freeligand receptormoleculesnanoparticlesPharmaDiagnosticsPKplate readerproteinprotein bindingscreeningSopranosurface plasmon resonance

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2017 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!
X
Are you interested in this product?
If you'd like to reach out to you with more information about this product, please supply your email and they will contact you.

Email Address:
Stop showing me this for the remainder of my visit